Grifols S.A.    

 
MADRID: GRF

Address:

Marina 16-18, Planta 26

Barcelona, E-08005

Spain

Phone:
34 93 371 05 00

Fax:
34 93 571 02 67


Company description

Manufacturing: Head of a Group of Companies with interest in the production of pharmaceutical and diagnostic products

Log in for comprehensive information about this and hundreds of thousands of other companies.

News and information about Grifols S.A.

Research and Markets Offers Report: Nucleic Acid Amplification Testing Market 2014 - 2025
Entertainment Close-up; April 4, 2017; 455 words
...Hoffmann-La Roche -Siemens Healthcare GmbH -Bio-Rad Laboratories, Inc. -bioMerieux SA -Illumina, Inc. -Grifols SA -Beckman Coulter, Inc. -Abbott -Hologic, Inc. More information: www.researchandmarkets.com/research/lxrlxr...
Hologic Will Buy Cynosure for $1.65 Billion
The Boston Globe (Boston, MA); February 15, 2017; 700+ words
...expecting Hologic to make acquisitions. In December, the company sold its share of a blood-screening business to partner Grifols SA for $1.85 billion. In its last fiscal year, Hologic reported profit of $330.8 million on sales of $2.83 billion...
Research and Markets Adds Report: Burkholderia Pseudomallei Infections (Melioidosis) - Pipeline Review, H2 2016
Manufacturing Close-Up; December 23, 2016; 420 words
...ResearchExpert Panel ValidationContact UsDisclaimerCompanies Mentioned-Bavarian Nordic A/S-Emergent BioSolutions-Grifols SA-Soligenix-SyntironReport Information:http://www.researchandmarkets.com/research/h5lgct/burkholderia...
Hologic Inc. Sells Its Share of Blood Screening Business
The Boston Globe (Boston, MA); December 15, 2016; 700+ words
...business Hologic Inc. said Wednesday it has sold its share of a blood screening business to Spanish pharmaceutical company Grifols SA for $1.8 billion, bringing in revenue to accelerate growth at the Marlborough-based medical device maker. The...
Red Notice - October 2016
Mondaq Business Briefing; November 9, 2016; 700+ words
...information, see the SEC notice and coverage in The FCPA Blog. Grifols SA Announces Declination by DOJ Spanish pharmaceutical company Grifols SA ("Grifols") announced in an SEC filing on October...
Red Notice Newsletter - October 2016
Mondaq Business Briefing; November 2, 2016; 700+ words
...information, see the SEC notice and coverage in The FCPA Blog. Grifols SA Announces Declination by DOJ Spanish pharmaceutical company Grifols SA ("Grifols") announced in an SEC filing on October...
Biotech Boon
Business North Carolina; July 1, 2016; 700+ words
...Convention. Johnston's largest private employer, with about 1,650 employees, is Barcelona-based plasma producer Grifols SA, which also has plans for a $210 million expansion (page 57).The world's largest insulin maker, Novo already...
Research and Markets Adds Report: Global Blood Plasma Market - Analysis, Technologies & Forecasts Report 2015-2020
Health & Beauty Close-Up; January 26, 2016; 356 words
...during 2015 - 2020. Few of the leading companies operating in blood plasma market in world include CSL Behring, Baxter, Grifols SA and Octapharma, etc. Companies Mentioned: -Amag Pharmaceuticals, Inc. -Antares Pharma Inc -Baxter International...

Search HighBeam Business for more news about Grifols S.A.

Industry information

NAICS codes 
North American Industry Classification System (NAICS) codes are used to classify businesses for the purpose of collecting statistical data related to the U.S. economy. NAICS codes have been assigned to international companies to help organize all companies by type of activity.  

Primary: 325412 - Pharmaceutical Preparation Manufacturing

325411 - Medicinal and Botanical Manufacturing

325413 - In-Vitro Diagnostic Substance Manufacturing


 

SIC codes 
Standard Industrial Classification (SIC) codes classify establishments by their primary type of activity. SIC codes are a U.S. Census Bureau system but can apply to international companies.  

Primary: 2834 - Pharmaceutical Preparations industry report

2833 - Medicinal Chemicals and Botanical Products industry report

2835 - In Vitro and In Vivo Diagnostic Substances industry report